HIV-related lymphoma treated with maintenance thalidomide

Clin Adv Hematol Oncol. 2005 Mar;3(3):231-4; discussion 234-5.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Axilla
  • Carboplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Immunotherapy
  • Lymphatic Irradiation
  • Lymphoma, AIDS-Related / drug therapy*
  • Lymphoma, AIDS-Related / radiotherapy
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy
  • Male
  • Prednisone / administration & dosage
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Rituximab
  • Thalidomide / therapeutic use*
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Thalidomide
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Carboplatin
  • Ifosfamide
  • Prednisone

Supplementary concepts

  • CHOP protocol
  • ICE protocol 3